TIM3 Expression in Anaplastic-Thyroid-Cancer-Infiltrating Macrophages: An Emerging Immunotherapeutic Target

TIM3 Expression in Anaplastic-Thyroid-Cancer-Infiltrating Macrophages: An Emerging Immunotherapeutic Target

Anaplastic thyroid cancer (ATC) is a clinically aggressive form of undifferentiated thyroid cancer with limited treatment options. Immunotherapy for patients with ATC remains challenging. Tumor-associated macrophages (TAMs) constitute over 50% of ATC-infiltrating cells, and their presence is associa...

Full description

Bibliographic Details
Main Authors: Luz Maria Palacios, Victoria Peyret, María Estefania Viano, Romina Celeste Geysels, Yair Aron Chocobar, Ximena Volpini, Claudia Gabriela Pellizas, Juan Pablo Nicola, Claudia Cristina Motran, María Cecilia Rodriguez-Galan, Laura Fozzatti
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Biology
Subjects:
anaplastic thyroid cancer
tumor-associated macrophages
M2-like macrophage polarization
TIM3
immunotherapy
Online Access:https://www.mdpi.com/2079-7737/11/11/1609

Internet

https://www.mdpi.com/2079-7737/11/11/1609

Similar Items